Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
20 November, 2018 18:55 IST
Alembic Pharma gets USFDA tentative approval for Ticagrelor Tablets
Source: IRIS | 12 Jul, 2018, 10.40AM
Comments  |  Post Comment

Alembic Pharmaceuticals today announced that the company has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Ticagrelor Tablets, 90 mg.

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Brilinta Tablets, 90 rng, of Astrazeneca Pharmaceuticals LP. Ticagrelor tablets are indicated to reduce the rate of cardiovascular death, myocardial infarction, and stroke in patients with acute coronary syndrome (ACS) or a history of myocardial infarction (Ml).

Ticagrelor Tablets, 90 mg have an estimated market size of USD 625 million for twelve months ending December 2017 according to IQVIA.

Alembic now has a total of 75 ANDA approvals (65 final approvals and 10 tentative approvals) from USFDA.

Shares of the company gained Rs 5.75, or 1.08%, to trade at Rs 536.65. The total volume of shares traded was 678 at the BSE (10.27 a.m., Thursday).



Alembic Pharmaceuticals Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Gayatri Projects declared as lowest bidder for project worth Rs 1.62 bn - 20-Nov-2018 14:55
Ramco Systems wins contract from leading casino and resorts provider - 20-Nov-2018 14:52
Zydus Cadila receives tentative approval for Deferasirox tablets - 20-Nov-2018 14:49
Kridhan Infra arm wins orders worth Rs 1.95 bn - 20-Nov-2018 09:35
Glenmark Pharma receives approval for Azelaic acid gel - 20-Nov-2018 09:31
PSP Projects' total work order stands at Rs 8.04 bn in FY19 - 20-Nov-2018 09:28
TCS partners with SAP to build intelligent rail digital maintenance solution - 20-Nov-2018 09:27
Zydus receives final approval from USFDA for Abacavir & Lamivudine Tablets and Fondaparinux Sodium Injection - 19-Nov-2018 09:51
Infosys starts construction of U.S education center in Indianapolis - 19-Nov-2018 09:41
Infosys completes formation of JV with Temasek - 19-Nov-2018 09:37
SPML Infra wins arbitration award against Jharkhand Urja Utpadan Nigam - 19-Nov-2018 09:34
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer